
### [MONDO:0020124](http://purl.obolibrary.org/obo/MONDO_0020124)
**Label:** neuromuscular junction disease

**Subclasses:** [MONDO:0018743](http://purl.obolibrary.org/obo/MONDO_0018743) (immune-mediated acquired neuromuscular junction disease), [MONDO:0016468](http://purl.obolibrary.org/obo/MONDO_0016468) (toxin-mediated infectious botulism), [MONDO:0018940](http://purl.obolibrary.org/obo/MONDO_0018940) (congenital myasthenic syndrome), [MONDO:0005498](http://purl.obolibrary.org/obo/MONDO_0005498) (botulism), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), [MONDO:0009688](http://purl.obolibrary.org/obo/MONDO_0009688) (myasthenia gravis), [MONDO:0020344](http://purl.obolibrary.org/obo/MONDO_0020344) (postsynaptic congenital myasthenic syndromes), [MONDO:0015805](http://purl.obolibrary.org/obo/MONDO_0015805) (intestinal botulism), [MONDO:0020125](http://purl.obolibrary.org/obo/MONDO_0020125) (acquired neuromuscular junction disease), [MONDO:0020345](http://purl.obolibrary.org/obo/MONDO_0020345) (presynaptic congenital myasthenic syndromes), [MONDO:0020346](http://purl.obolibrary.org/obo/MONDO_0020346) (synaptic congenital myasthenic syndromes), 

**Corr. equiv. classes:** [Orphanet:98494](http://www.orpha.net/ORDO/Orphanet_98494), [Orphanet:1267](http://www.orpha.net/ORDO/Orphanet_1267), [Orphanet:98913](http://www.orpha.net/ORDO/Orphanet_98913), [Orphanet:590](http://www.orpha.net/ORDO/Orphanet_590), [Orphanet:178481](http://www.orpha.net/ORDO/Orphanet_178481), [Orphanet:98914](http://www.orpha.net/ORDO/Orphanet_98914), [Orphanet:98915](http://www.orpha.net/ORDO/Orphanet_98915), [Orphanet:353327](http://www.orpha.net/ORDO/Orphanet_353327), [OMIM:254200](http://purl.obolibrary.org/obo/OMIM_254200), [Orphanet:464764](http://www.orpha.net/ORDO/Orphanet_464764), [Orphanet:230800](http://www.orpha.net/ORDO/Orphanet_230800), [Orphanet:589](http://www.orpha.net/ORDO/Orphanet_589), 

**Class expressions from DL-Learner:**

- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0002015](http://purl.obolibrary.org/obo/HP_0002015) (Dysphagia) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012719](http://purl.obolibrary.org/obo/HP_0012719) (Functional abnormality of the gastrointestinal tract) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 66.48%
- [HP:0000651](http://purl.obolibrary.org/obo/HP_0000651) (Diplopia) and [HP:0000759](http://purl.obolibrary.org/obo/HP_0000759) (Abnormal peripheral nervous system morphology) and [HP:0001324](http://purl.obolibrary.org/obo/HP_0001324) (Muscle weakness) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) 66.48%


